| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0135 |
Injection, adalimumab, 20 mg |
1,125 |
1,040 |
$4.73M |
| J1438 |
Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
536 |
486 |
$1.15M |
| J3490 |
Unclassified drugs |
1,494 |
1,394 |
$853K |
| J3590 |
Unclassified biologics |
473 |
444 |
$724K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
622 |
619 |
$593K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
253 |
165 |
$131K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
238 |
107 |
$117K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
31 |
24 |
$42K |
| 90750 |
|
137 |
137 |
$33K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
122 |
54 |
$27K |
| 0011A |
|
26 |
26 |
$1K |
| 0012A |
|
20 |
20 |
$800.00 |
| S9542 |
Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
57 |
54 |
$26.25 |